HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIV-positive patient Journal Article


Authors: Guerrero, C.; Jain, T.; Kelemen, K.
Article Title: HHV-8-associated lymphoproliferative disorders and pathogenesis in an HIV-positive patient
Abstract: Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus, is a DNA oncovirus known for its role in the development of Kaposi's sarcoma (KS) and several lymphoproliferative disorders (LPDs). HHV-8 promotes lymphoproliferation via the activation of the interleukin-6 receptor signaling pathway, as well as a host of other regulatory mechanisms. The spectrum of HHV-8-associated LPDs is increasing. The World Health Organization has recently updated the classification of HHV-8-associated LPDs by introducing HHV-8-positive germinotropic LPD (GLPD) in addition to the previously recognized entities of HHV-8-positive diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS), primary effusion lymphoma (PEL), and HHV-8-positive multicentric Castleman's disease (MCD). We present here a case of an HIV-positive woman with a history of KS, who later developed three HHV-8-associated LPDs, including HHV-8-positive MCD, PEL, and GLPD. To the best of our knowledge, this is the first reported case of a patient with this combination of individually rare HHV-8-associated LPDs. This case illustrates the spectrum and the sequential development of the different clinical manifestations of HHV-8-associated diseases. Detection of HHV-8 can have clinical significance in the diagnosis and management of certain HHV-8-associated conditions. Recently discovered variants of HHV-8-associated LPDs indicate that this group represents a diverse spectrum of disorders, whose classification may require further refinement beyond the currently recognized entities.
Keywords: spectrum; nf-kappa-b; kaposis-sarcoma; herpesvirus; primary effusion lymphoma
Journal Title: Case Reports in Hematology
Volume: 2019
ISSN: 2090-6560
Publisher: Hindawi Ltd  
Date Published: 2019-08-22
Start Page: 4536157
Language: English
ACCESSION: WOS:000484706800001
DOI: 10.1155/2019/4536157
PROVIDER: wos
PMCID: PMC6724429
PUBMED: 31534804
Notes: Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tania Jain
    27 Jain